Sen. John Kennedy (R-LA) lambasted Republicans on Tuesday for being sluggish in passing bipartisan legislation to lower prescription drug prices during the first two years of the Trump presidency.
Kennedy criticized his party’s leadership on the issue of reigning in pharmacy benefits managers, or PBMs, and other middlemen in the drug industry during a Senate Judiciary Committee hearing on how competition and transparency would put downward pressure on prices.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.